Trials / Unknown
UnknownNCT04920851
Cytokine Hemadsorption in Covid 19 Patients With Bacterial Sepsis
Comparison of Cytokine Hemadsorption as an Immunomodulator Therapy in Covid 19 Patients With and Without Bacterial Sepsis
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 23 (estimated)
- Sponsor
- Derince Training and Research Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
In this retrospective study, we aimed to compare the laboratory and clinical results of cytokine hemadsorption as an immunomodulation therapy in COVID-19 ICU patients with or without sepsis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | cytokine hemadsorption | to compare the laboratory and clinical results of cytokine hemadsorption as an immunomodulation therapy in COVID-19 ICU patients with or without sepsis. |
Timeline
- Start date
- 2021-06-10
- Primary completion
- 2021-07-05
- Completion
- 2021-07-20
- First posted
- 2021-06-10
- Last updated
- 2021-06-10
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT04920851. Inclusion in this directory is not an endorsement.